Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Givinostat in ambulant adults with Becker muscular dystrophy
2017-001629-41Phase 2Completed
- Sponsor
- Italfarmaco
- Start
- May 2018
- Modality
- Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in Becker muscular dystrophy (BMD) comparing Givinostat with Placebo (2 arms). Primary endpoint: Change in muscle biopsy cross-sectional area. Started May 2018; status: completed.
02
Drugs
givinostat
03
Conditions
Becker muscular dystrophy (BMD)
Beyond the preview
Go deeper on 2017-001629-41.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2017-001629-41.